Wall Street analysts expect that Boston Scientific Co. (NYSE:BSX – Get Rating) will announce $3.22 billion in sales for the current quarter, Zacks Investment Research reports. Nine analysts have issued estimates for Boston Scientific’s earnings, with the lowest sales estimate coming in at $3.20 billion and the highest estimate coming in at $3.24 billion. Boston […]
Analysts expect Boston Scientific Co. (NYSE:BSX – Get Rating) to post sales of $3.22 billion for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have provided estimates for Boston Scientific’s earnings, with the lowest sales estimate coming in at $3.20 billion and the highest estimate coming in at $3.24 billion. Boston Scientific […]
Boston Scientific Co. (NYSE:BSX – Get Rating) was the recipient of a large decrease in short interest in April. As of April 15th, there was short interest totalling 11,970,000 shares, a decrease of 23.6% from the March 31st total of 15,670,000 shares. Based on an average daily volume of 9,060,000 shares, the days-to-cover ratio is […]
Equities researchers at Truist Financial assumed coverage on shares of Boston Scientific (NYSE:BSX – Get Rating) in a report released on Wednesday, FinViz reports. The brokerage set a “buy” rating and a $52.00 price target on the medical equipment provider’s stock. Truist Financial’s target price points to a potential upside of 17.14% from the company’s […]
Equities research analysts forecast that Boston Scientific Co. (NYSE:BSX – Get Rating) will post earnings per share (EPS) of $0.39 for the current quarter, Zacks Investment Research reports. Eight analysts have provided estimates for Boston Scientific’s earnings, with estimates ranging from $0.38 to $0.39. Boston Scientific posted earnings per share of $0.37 in the same […]